AimMax® Therapeutics, Inc. (AimMax), is a company engaging in the research and development of biopharmaceuticals at various stages through in-licensing or co-development with strategic partners.
The company was founded in 2017 by pharmaceutical R&D professionals with diverse and synergistic backgrounds.
Company Core Strengths
- Translational Medicine: To advance early-stage molecules, from lead optimization to clinical proof of principle by understanding the molecules, the science and disease models
- Clinical Trial Design and Operations: To incorporate innovative trial design and data analysis to maximize clinical trial efficiency and the success of pivotal trials
- Regulatory and Commercial Strategies: To position the product for optimal labeling and commercial potential
- Passion and Dedication: To benefit the patients and health care community